Working… Menu

Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02391415
Recruitment Status : Completed
First Posted : March 18, 2015
Last Update Posted : April 18, 2018
Vakzine Projekt Management GmbH
Triclinium Clinical Trial Project Management
Children's Infectious Diseases Clinical Research Unit (KID-CRU)
Desmond Tutu TB Centre
The Respiratory and Meningeal Pathogens Research Unit (RMPRU)
South African Tuberculosis Vaccine Initiative
University of Stellenbosch
Information provided by (Responsible Party):
Serum Institute of India Pvt. Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2017
Actual Study Completion Date : November 2017